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mesothelial cells,” but, to our knowledge, these authors
never employed immunohistochemical analysis in any of
their published papers on peritoneal biopsy morphology.
Immunohistochemistry is absolutely necessary to distin-
guish the different fibroblastic subpopulations in the peri-
toneal tissue before and during peritoneal dialysis (PD).
In a recent and ulterior study [3], we have further con-
firmed the existence of a fibroblast subpopulation derived
from the mesothelium in patients undergoing PD.
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Reply from the Authors
Dr. Selgas and his colleagues suggest in their letter that
our recently published review [1] was unreasonably criti-
cal of their paper in the New England Journal of Medicine
[2] and was based on personal rather than scientific opin-
ion. In fact, our review was fully referenced, including
the statements used in the critique of Dr. Selgas’ paper.
We believe that there is data available in the scientific
literature that they have chosen not to consider, and we
indicated this in our publication. Furthermore, we indi-
cated that their presentation of peritoneal morphology is
in contrast to that with which we are familiar.
With regard to our relationship to the Peritoneal
Biopsy Registry, we wish to make it clear that the opin-
ions expressed in the review are solely those of the named
authors. We do acknowledge the donation of peritoneal
tissue by all the centers listed at the end of our review,
and we apologize for any confusion caused. The opin-
ions of the authors are based on the experience gained
by examination of this collection of biopsies.
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A catalog of gene expression in
the developing kidney
To the Editor: In a recent paper, Schwab et al [1] pro-
vided an extensive description of gene expression dur-
ing mouse nephrogenesis by coupling microarrays and
robust target microamplification techniques. In addition
to other evidences of kidney stepwise organogenesis in
the rat [2], this work established very useful baselines
for further investigations of mouse nephrogenesis. How-
ever, one should emphasize that gene regulation only rep-
resents the first step of tissue differentiation that should
be complemented by studies at the protein level. We have
recently described ontogeny patterns of proximal tubule
(PT) transporters during mouse and human nephrogene-
sis, showing that PT maturation was essentially achieved
at the initiation of glomerular filtration [3]. The compar-
ison of data obtained by real-time polymerase chain re-
action (PCR) and immunoblotting in mouse embryonic
kidneys clearly shows that divergent ontogeny pat-
terns can be observed at the mRNA and protein lev-
els (Fig. 1). Additional differences may also arise from
post-translational modifications, such as complex N-
glycosylation, which may also be regulated during on-
togeny and plays a significant role in protein maturation
[3]. In conclusion, gene expression analyses represent a
powerful tool to identify and compare pathways involved
in regular and mutant embryogenesis [4]. However, the
complexity of post-transcriptional regulations should be
considered when integrating the factors involved in dif-
ferentiation and organogenesis cascades.
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Fig. 1. Comparative ontogeny of the chloride channel ClC-5, the
E1 subunit of the vacuolar H+-ATPase, and the water channel
AQP1 in mouse kidney. Quantitative real-time PCR results (A to
C, black bar) and densitometry analyses of immunoblots (A to C,
grey bar) of ClC-5 (A), H+-ATPase E1 subunit (B), and AQP1
(C) expression in embryonic (E13.5, E15.5, E17.5), neonatal, and
adult mouse kidneys. Real-time PCR analyses were performed by ad-
justing ClC-5, H+-ATPase E1 subunit, and AQP1 mRNA levels to
GAPDH at each stage, and comparing the relative changes in ex-
pression during ontogeny to the adult level (taken as 100%). Ratio =
(Etarget)Ct(Adult-sample)/(EGAPDH)Ct(Adult-sample). The analyses were
performed in duplicate on pooled samples from an average of 12 em-
bryos, from 4 different litters. Densitometry analyses of specific im-
munoreactive bands were performed with a Hewlett Packard Scan-
jet model IVC using the NIH Image V1.60 software. Optical densities
were normalized to b-actin density in the corresponding sample. All
immunoblots were at least performed in duplicate. The early (E13.5)
induction of ClC-5 mRNA transcription was followed by a decrease
during late nephrogenesis, whereas ClC-5 protein expression was sta-
ble from E14.5 until birth (A). For the E1 subunit of the H+-ATPase,
its stable mRNA expression during nephrogenesis contrasted with a
late (E16.5) and progressive detection of the protein (B). Finally, AQP1
mRNA detection was paralleled by a progressive protein expression and
maturation (N-glycosylation) during late ontogeny (C). The ontogeny
of these three transporters mostly expressed in the proximal tubule of
the nephron illustrates that significant differences can be observed be-
tween mRNA and protein expression patterns during nephrogenesis.
The data have been compiled and adapted from [3].
Urea space and body water
To the Editor: PICARD program investigators re-
ported larger kinetic urea distribution volumes (Vurea)
than anthropometric body water (TBW) in acute renal
failure (ARF) patients [1]. They now find larger [13C]urea-
measured Vurea than both D2O-measured and anthropo-
metric TBW [2]. TBW measured by D2O (38.3 L) was
close to anthropometric estimates (38.3 and 39.3 L); the
correlation between them and isotopic TBW were highly
significant (Ps ≤ 0.01). Thus, anthropometric methods
estimated TBW reasonably well, as they were designed
to do. Vurea (51.0 L), however, was higher (about 30%)
than TBW and correlated weakly or not at all with TBW
(Ps ≥ 0.04). Bioimpedance estimated that volumes were
between Vurea and TBW.
These findings are interesting, stimulating, and infor-
mative because HEMO Study investigators report higher
anthropometric TBW (about 20%) than kinetic Vurea in
chronic renal failure (CRF) patients [3]. Thus, Vurea ap-
pears much higher than TBW in ARF, but much lower
than TBW in CRF. What happens to Vurea in CRF pa-
tients who become ill, or ARF patients who become
chronic?
What should clinicians with good estimates of TBW—
thought to equal Vurea until very recently—do? Should
they increase prescribed Kt by 30% in ARF, but reduce
it by 20% in CRF to achieve comparable Kt/Vurea? Or
should nephrologists who treat dialysis patients rejoin
the ranks of other clinicians who use less ambiguous
body size measures, such as body surface area or body
weight [4], to judge physiologic functions and to prescribe
treatments?
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